✦ LIBER ✦

PMC37 PATIENT REPORTED OUTCOME RECALL PERIODS IN LIGHT OF THE FINAL FDA GUIDANCE

✍ Scribed by D Wild; A Nixon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMC37 ACCESS TO PATIENT-REPORTED OUTCOME

✍ C Anfray; MP Emery 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PMC48 UPDATE OF TRENDS IN THE INCLUSION

✍ M Caron; MP Emery; P Marquis; E Piault 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PMC55 IMPACT OF THE FDA DRAFT GUIDANCE O

✍ M Mordin; M Clark; C Siersma; K Copley-Merriman; A Gnanasakthy 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Guidance for industry: patient-reported

✍ U.S. Department of Health and Human Services FDA Center for Drug Evaluation and 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 583 KB

UT2 Update of The Patient-Reported Outco

✍ M. Caron; L.L. Perrier; V. Vaissier; I. Savre; C. Acquadro; M.P. Emory 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Use of pain instruments as endpoints in

✍ P. Black; A. Shields; K. Halling 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 33 KB